389 related articles for article (PubMed ID: 8143011)
1. A search for persistent measles, mumps, and rubella vaccine virus in children with human immunodeficiency virus type 1 infection.
Frenkel LM; Nielsen K; Garakian A; Cherry JD
Arch Pediatr Adolesc Med; 1994 Jan; 148(1):57-60. PubMed ID: 8143011
[TBL] [Abstract][Full Text] [Related]
2. Measles, mumps and rubella immunisation in children at risk of infection with human immunodeficiency virus.
Molyneaux PJ; Mok JY; Burns SM; Yap PL
J Infect; 1993 Nov; 27(3):251-3. PubMed ID: 8308316
[TBL] [Abstract][Full Text] [Related]
3. Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection.
Dennehy PH; Saracen CL; Peter G
Pediatrics; 1994 Oct; 94(4 Pt 1):514-6. PubMed ID: 7936862
[TBL] [Abstract][Full Text] [Related]
4. Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years.
Johnson CE; Kumar ML; Whitwell JK; Staehle BO; Rome LP; Dinakar C; Hurni W; Nalin DR
Pediatr Infect Dis J; 1996 Aug; 15(8):687-92. PubMed ID: 8858673
[TBL] [Abstract][Full Text] [Related]
5. Immunity to and immunization against measles, rubella and mumps in patients after autologous bone marrow transplantation.
Pauksen K; Duraj V; Ljungman P; Sjölin J; Oberg G; Lönnerholm G; Fridell E; Smedmyr B; Simonsson B
Bone Marrow Transplant; 1992 Jun; 9(6):427-32. PubMed ID: 1628126
[TBL] [Abstract][Full Text] [Related]
6. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
Zäch K; Nicoara C; Germann D; Matter L
Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
[TBL] [Abstract][Full Text] [Related]
7. The combination measles, mumps, rubella and varicella vaccine in healthy children.
Arbeter AM; Baker L; Starr SE; Plotkin SA
Dev Biol Stand; 1986; 65():89-93. PubMed ID: 3030864
[TBL] [Abstract][Full Text] [Related]
8. Measles, mumps, and rubella antibodies in vaccinated Baltimore children.
King JC; Lichenstein R; Feigelman S; Luna C; Permutt TJ; Patel J
Am J Dis Child; 1993 May; 147(5):558-60. PubMed ID: 8488803
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a combined measles-mumps-rubella-chickenpox vaccine.
Just M; Berger R; Just V
Dev Biol Stand; 1986; 65():85-8. PubMed ID: 3030863
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine.
Ljungman P; Fridell E; Lönnqvist B; Bolme P; Böttiger M; Gahrton G; Linde A; Ringdén O; Wahren B
J Infect Dis; 1989 Apr; 159(4):610-5. PubMed ID: 2647859
[TBL] [Abstract][Full Text] [Related]
11. Decline in rates of seropositivity for measles, mumps, and rubella antibodies among previously immunized children treated for acute leukemia.
Feldman S; Andrew M; Norris M; McIntyre B; Iyer R
Clin Infect Dis; 1998 Aug; 27(2):388-90. PubMed ID: 9709893
[TBL] [Abstract][Full Text] [Related]
12. Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella.
Tischer A; Gerike E
Vaccine; 2000 Jan; 18(14):1382-92. PubMed ID: 10618536
[TBL] [Abstract][Full Text] [Related]
13. Serologic response to measles-mumps-rubella vaccine among children with upper respiratory tract infection.
Cilla G; Peña B; Marimón JM; Pérez-Trallero E
Vaccine; 1996 Apr; 14(6):492-4. PubMed ID: 8782345
[TBL] [Abstract][Full Text] [Related]
14. [The immunological efficacy of the combined vaccine Trimovax intended for the prevention of measles, mumps and rubella].
Samoĭlovich EO; Kapustik LA; Fel'dman EV; Ermolovich MA; Svirchevskaia EIu; Titov LP; Zakharenko DF; Belova EIu; Chernovetskiĭ MA; Korostik TS
Zh Mikrobiol Epidemiol Immunobiol; 1998; (4):36-40. PubMed ID: 9783398
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of two combined measles-mumps-rubella vaccines based on AIK and Edmonston- Zagreb strains of measles virus.
Mirchamsy H; Nilforoushan MA; Shafyi A; Razavi J; Ashtiani MP; Youssofi I; Sassani A; Fateh G; Nassiri S
Kitasato Arch Exp Med; 1991 Sep; 64(2-3):141-7. PubMed ID: 1811112
[TBL] [Abstract][Full Text] [Related]
16. Changes of the immunological patterns against measles, mumps and rubella. A vaccination programme studied 3 to 7 years after the introduction of a two-dose schedule.
Christenson B; Böttiger M
Vaccine; 1991 May; 9(5):326-9. PubMed ID: 1872016
[TBL] [Abstract][Full Text] [Related]
17. Effect of simultaneous administration of live measles vaccine on the "take rate" of live mumps vaccine.
André FE; Peetermans J
Dev Biol Stand; 1986; 65():101-7. PubMed ID: 3556770
[TBL] [Abstract][Full Text] [Related]
18. Antibody response to measles-mumps-rubella vaccine of children with mild illness at the time of vaccination.
King GE; Markowitz LE; Heath J; Redd SC; Coleman S; Bellini WJ; Sievert A
JAMA; 1996 Mar; 275(9):704-7. PubMed ID: 8594268
[TBL] [Abstract][Full Text] [Related]
19. Measles, mumps, rubella antibody surveillance: pilot study in Grampian, Scotland.
Narayan KM; Moffat MA
Health Bull (Edinb); 1992 Jan; 50(1):47-53. PubMed ID: 1612895
[TBL] [Abstract][Full Text] [Related]
20. Determination of measles, mumps, and rubella immunization status using oral fluid samples.
Thieme T; Piacentini S; Davidson S; Steingart K
JAMA; 1994 Jul; 272(3):219-21. PubMed ID: 8022041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]